Holekamp NM, Campochiaro PA, Chang M, Miller D, et al. Archway Randomized Phase 3 Trial of the Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology 2021 Sep 28. pii: S0161-6420(21)00734.
PMID: 34597713